Abstract
Monocytes/macrophages are a heterogeneous cell population that play a critical role in host defense and tissue homeostasis. However, macrophage activation during acute and chronic inflammation can result in macrophage-mediated renal injury in a variety of settings, including proliferative glomerulonephritis. Macrophages can be activated via a number of intracellular signaling pathways (eg, c-Jun amino terminal kinase, p38 mitogen-activated protein kinase, FcR/Syk, Janus kinase/signal transducer and activator of transcription) that induce production of mediators of renal injury. Thus, targeting selected macrophage signaling pathways is a potential therapeutic strategy to suppress macrophage-mediated renal injury while leaving intact the desirable macrophage functions of host defense and tissue repair.
| Original language | English |
|---|---|
| Pages (from-to) | 334-344 |
| Number of pages | 11 |
| Journal | Seminars in Nephrology |
| Volume | 30 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 05-2010 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Nephrology
Fingerprint
Dive into the research topics of 'Macrophage signaling pathways: A novel target in renal disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver